跳至主要内容
临床试验/EUCTR2006-002000-34-ES
EUCTR2006-002000-34-ES进行中(未招募)不适用

CLOZAPINA EN PRIMEROS BROTES DE ESQUIZOFRENIA COMO POSIBLE TRATAMIENTO PREVENTIVO DEL DETERIORO CEREBRAL Y CLINICO

Fundación Cerebro y Mente0 个研究点开始时间: 2007年1月24日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Schizophrenia (DSM-IV), with a duration lesser than one year, -
  • -Potential clinical benefit from the drugs oninvestigation.
  • - Informed consent form the patient and family
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Very obvious estresors related to the onset on psychoses
  • Any other axis I process
  • Cranial traumatism with loss of conscioussness longer than one minute
  • Sustance abuse
  • Contraindication for magnetic resonance imaging

研究者

发起方
Fundación Cerebro y Mente

相似试验